96 related articles for article (PubMed ID: 15572566)
1. Comparing the quality of antidepressant pharmacotherapy in the Department of Veterans Affairs and the private sector.
Busch SH; Leslie DL; Rosenheck RA
Psychiatr Serv; 2004 Dec; 55(12):1386-91. PubMed ID: 15572566
[TBL] [Abstract][Full Text] [Related]
2. Benchmarking the quality of schizophrenia pharmacotherapy: a comparison of the Department of Veterans Affairs and the private sector.
Leslie DL; Rosenheck RA
J Ment Health Policy Econ; 2003 Sep; 6(3):113-21. PubMed ID: 14646004
[TBL] [Abstract][Full Text] [Related]
3. Comparing quality of mental health care for public-sector and privately insured populations.
Leslie DL; Rosenheck RA
Psychiatr Serv; 2000 May; 51(5):650-5. PubMed ID: 10783185
[TBL] [Abstract][Full Text] [Related]
4. Measuring quality of pharmacotherapy for depression in a national health care system.
Busch SH; Leslie D; Rosenheck R
Med Care; 2004 Jun; 42(6):532-42. PubMed ID: 15167321
[TBL] [Abstract][Full Text] [Related]
5. Predictors of persistence of comorbid generalized anxiety disorder among veterans with major depressive disorder.
Mittal D; Fortney JC; Pyne JM; Wetherell JL
J Clin Psychiatry; 2011 Nov; 72(11):1445-51. PubMed ID: 21208594
[TBL] [Abstract][Full Text] [Related]
6. The Quality of Medication Treatment for Mental Disorders in the Department of Veterans Affairs and in Private-Sector Plans.
Watkins KE; Smith B; Akincigil A; Sorbero ME; Paddock S; Woodroffe A; Huang C; Crystal S; Pincus HA
Psychiatr Serv; 2016 Apr; 67(4):391-6. PubMed ID: 26567931
[TBL] [Abstract][Full Text] [Related]
7. Methods for estimating and comparing VA outpatient drug benefits with the private sector.
Render ML; Nowak J; Hammond EK; Roselle G
Med Care; 2003 Jun; 41(6 Suppl):II61-9. PubMed ID: 12773828
[TBL] [Abstract][Full Text] [Related]
8. Depression care following psychiatric hospitalization in the Veterans Health Administration.
Pfeiffer PN; Ganoczy D; Bowersox NW; McCarthy JF; Blow FC; Valenstein M
Am J Manag Care; 2011 Sep; 17(9):e358-64. PubMed ID: 21902443
[TBL] [Abstract][Full Text] [Related]
9. Trends in antidepressant prescribing for new episodes of depression and implications for health system quality measures.
Pfeiffer PN; Szymanski BR; Valenstein M; McCarthy JF; Zivin K
Med Care; 2012 Jan; 50(1):86-90. PubMed ID: 22182925
[TBL] [Abstract][Full Text] [Related]
10. Mortality of Department of Veterans Affairs patients undergoing coronary revascularization in private sector hospitals.
Vaughan-Sarrazin MS; Wakefield B; Rosenthal GE
Health Serv Res; 2007 Oct; 42(5):1802-21. PubMed ID: 17850521
[TBL] [Abstract][Full Text] [Related]
11. Inadequate follow-up care for depression and its impact on antidepressant treatment duration among veterans with and without diabetes mellitus in the Veterans Health Administration.
Jones LE; Turvey C; Carney-Doebbeling C
Gen Hosp Psychiatry; 2006; 28(6):465-74. PubMed ID: 17088161
[TBL] [Abstract][Full Text] [Related]
12. Psychotherapy and pharmacotherapy in depression.
Powers RH; Kniesner TJ; Croghan TW
J Ment Health Policy Econ; 2002 Dec; 5(4):153-61. PubMed ID: 14578549
[TBL] [Abstract][Full Text] [Related]
13. Comparing VA and private sector healthcare costs for end-stage renal disease.
Hynes DM; Stroupe KT; Fischer MJ; Reda DJ; Manning W; Browning MM; Huo Z; Saban K; Kaufman JS;
Med Care; 2012 Feb; 50(2):161-70. PubMed ID: 21945972
[TBL] [Abstract][Full Text] [Related]
14. Comparison of risk-adjusted 30-day postoperative mortality and morbidity in Department of Veterans Affairs hospitals and selected university medical centers: general surgical operations in women.
Fink AS; Hutter MM; Campbell DC; Henderson WG; Mosca C; Khuri SF
J Am Coll Surg; 2007 Jun; 204(6):1127-36. PubMed ID: 17544071
[TBL] [Abstract][Full Text] [Related]
15. New York's statistical model accurately predicts mortality risk for veterans who obtain private sector CABG.
Weeks WB; Bazos DA; Bott DM; Lombardo R; Racz MJ; Hannan EL; Fisher ES
Health Serv Res; 2005 Aug; 40(4):1186-96. PubMed ID: 16033499
[TBL] [Abstract][Full Text] [Related]
16. PTSD and substance use disorder among veterans: characteristics, service utilization and pharmacotherapy.
Bowe A; Rosenheck R
J Dual Diagn; 2015; 11(1):22-32. PubMed ID: 25513763
[TBL] [Abstract][Full Text] [Related]
17. Veterans Health Administration patients' use of the private sector for coronary revascularization in New York: opportunities to improve outcomes by directing care to high-performance hospitals.
Weeks WB; Bott DM; Bazos DA; Campbell SL; Lombardo R; Racz MJ; Hannan EL; Wright SM; Fisher ES
Med Care; 2006 Jun; 44(6):519-26. PubMed ID: 16708000
[TBL] [Abstract][Full Text] [Related]
18. Use of antipsychotics in the treatment of major depressive disorder in the U.S. Department of Veterans Affairs.
Mohamed S; Leslie DL; Rosenheck RA
J Clin Psychiatry; 2009 Jun; 70(6):906-12. PubMed ID: 19422760
[TBL] [Abstract][Full Text] [Related]
19. Combined Use of Opioids and Antidepressants in the Treatment of Pain: A Review of Veterans Health Administration Data for Patients with Pain Both With and Without Co-morbid Depression.
Sellinger JJ; Sofuoglu M; Kerns RD; Rosenheck RA
Psychiatr Q; 2016 Dec; 87(4):585-593. PubMed ID: 26646578
[TBL] [Abstract][Full Text] [Related]
20. Detection and treatment of depression in a VA primary care clinic.
Foster MA; Ragsdale K; Dunne B; Jones E; Ihnen GH; Lentz C; Gilmore J
Psychiatr Serv; 1999 Nov; 50(11):1494-5. PubMed ID: 10543862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
